Patient info Open main menu

CELLUVISC 1% W/V EYE DROPS SOLUTION - patient leaflet, side effects, dosage

Dostupné balení:

Patient leaflet - CELLUVISC 1% W/V EYE DROPS SOLUTION

1. What Celluvisc is and what it is used for

2. What you need to know before you use Celluvisc

3. How to use Celluvisc

4. Possible side effects

5. How to store Celluvisc

6. Contents of the pack and other information

1. what celluvisc is and what it is used for

Celluvisc is a tear substitute and contains the lubricant called carmellose sodium. It is used for the treatment of the symptoms of dry eye (such as soreness, burning, irritation or dryness). You must talk to a doctor if you do not feel better or if you feel worse.

2. what you need to know before you use celluvisc

Do not use Celluvisc

  • If you are allergic (hypersensitive) to carmellose sodium or any of the other ingredients of this medicine (listed in section 6).
  • If you wear contact lenses, these should be removed before using Celluvisc. The lenses can be put back again 15 minutes after you have applied your drops.

Other medicines and Celluvisc

Please tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription.

If you are using other eye drops, leave at least 15 minutes before putting in Celluvisc.

Pregnancy and breast-feeding

Celluvisc can be used during pregnancy and breast-feeding.

Driving and using machines

Celluvisc may cause short-lasting blurring of vision typically lasting 1–15 minutes. If you do experience temporary blurring, do not drive or use machines until your sight is clear.

3. how to use celluvisc

Celluvisc is for ocular use (applied on the eye).

Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.

The recommended dose is 1–2 drops of Celluvisc in the affected eyes as needed.

Make sure that the single-dose container is intact before use. The solution should be used immediately after opening. To avoid contamination or possible eye injury, do not let the open-end of the singledose container touch your eye or anything else. Wash your hands before use.

  • 1. Tear one single-dose container from the strip.

  • 2. Hold the single-dose container upright (with the cap uppermost) and twist off the cap.

  • 3. Gently pull down the lower eyelid to form a pocket. Turn the single-dose container upside down and squeeze it to release one drop into each eye. Blink your eyes a few times.

4. possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The following adverse reactions or medically relevant adverse events were reported during clinical trials:

Common side effects (occurring in between 1 and 10 patients in every 100) are:

Eye irritation (including burning and discomfort), eye pain, itchy eyes, visual disturbance.

Post-Marketing Data

The following adverse reactions or medically relevant adverse events have been reported since the drug has been marketed.

Uncommon side effects (occurring in between 1 and 10 patients in every 1000) are: Allergic reactions (including eye or eyelid swelling), blurring of vision, increase in tear production (also known as tearing), sticky eye, crusting of the eyelid and/or drug residue, a feeling that something is in your eye, redness of the eye/eyelid, eyesight worsening, eye injury to the surface of the eye due to the tip of the vial touching the eye during use.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the

Yellow Card Scheme Website:.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. how to store celluvisc

KEEP ALL MEDICINES OUT OF THE SIGHT AND REACH OF CHILDREN.

Do not store above 25°C. Keep the single dose containers in the pouch and place the pouch back in the outer carton. Protect from light and moisture.

Do not use Celluvisc after the expiry date (Exp) printed on the carton label or the single-dose container tabs. The expiry date refers to the last day of that month.

If your doctor tells you to stop taking the medicine, please take it back to the pharmacist for safe disposal. Only keep the medicine if your doctor tells you to.

If your medicine appears to be discoloured or shows any signs of deterioration, please return to your pharmacist who will advise you further.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. contents of the pack and other information

What Celluvisc contains

Celluvisc contains carmellose sodium 1% w/v.

Also contains: sodium chloride, sodium lactate, potassium chloride, calcium chloride and purified water. The ingredients in Celluvisc were designed to match your natural tear composition.

What Celluvisc looks like and contents of the pack

Celluvisc is a clear to slightly yellow solution in a small, plastic and see-through (bubble-like) casing (known as a ‚single-dose container‘). Each single-dose container contains 0.4ml of solution and has a twist-off ‚cap‘. Each single-dose container also has a plastic ‚tab‘ telling you the name of the product on one side and the expiry/use by date on the other side.

Celluvisc is available as 30 × 0.4ml single-dose containers.

Each foil pouch contains 10 single-dose containers.

Manufacturer

Manufactured by: Allergan Pharmaceuticals Ireland, Westport, Co. Mayo, Ireland.

Procured from within the EU and repackaged by: Doncaster Pharmaceuticals Group Ltd., Kirk Sandall, Doncaster, DN3 1QR.

Product Licence holder: Landmark Pharma Ltd., 7 Regents Drive, Prudhoe, Northumberland, NE42 6PX.

PL No: 21828/0549 p

Leaflet revision & issue date (Ref): 08.12.20

Celluvisc® is a registered trademark of Allergan, Inc.

To listen to or request a copy of this leaflet in Braille, large print or audio, please contact 01302 365000 and ask for the Regulatory Department.

Please be ready to give the following information:

Product name: Celluvisc 1% w/v Eye Drops Solution

Reference number: 21828/0549